BioPort Anthrax Vaccine Cost To DoD Could Increase, CEO Says
Executive Summary
BioPort's price to the Department of Defense for its anthrax vaccine is likely to increase from the current price of about $11, BioPort CEO Robert Kramer told a Senate Appropriations/HHS Subcommittee hearing Oct. 23.